title: Amylin innocent in essential hypertension?
authors.forename: A
authors.initials: A
authors.lastname: Young
authors.forename: O
authors.initials: O
authors.lastname: Kolterman
authors.forename: J
authors.initials: J
authors.lastname: Hall
mesh_terms: D000682:Amyloid / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000503:physiopathology*; D003971:Diastole; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D058228:Islet Amyloid Polypeptide; D013599:Systole
chemical_list: D000682:Amyloid; D007004:Hypoglycemic Agents; D007328:Insulin; D058228:Islet Amyloid Polypeptide; C105254:pramlintide